BrefonalolAlternative Names: BDF 8186; Brefanolol
Latest Information Update: 24 Mar 1997
At a glance
- Originator Beiersdorf
- Class Antihypertensives; Ischaemic heart disorder therapies
- Mechanism of Action Alpha adrenergic receptor antagonists; Beta-adrenergic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Hypertension
Most Recent Events
- 24 Mar 1997 Discontinued-II for Hypertension in Germany (Unknown route)